Comparing two different doses of anti-thymocyte globulin in allogeneic hematopoietic stem cell transplantation for transfusion-dependent thalassemia: an open-label, randomized clinical trial

Qiulin Huang, Rongrong Liu, Baoshi Zheng, Lianjin Liu, Hongwen Xiao, Meiqing Wu, Lingling Shi, Gaohui Yang, Zhenbin Wei, Qi Zhou, Yinghua Chen, Yanye Liu, Jing Fan, Xuemei Zhou, Ruolin Li, Zhiyu Zeng, Zhongming Zhang, Yongrong Lai

Therapeutic Advances in Hematology

Published online on February 13, 2026

Abstract

Therapeutic Advances in Hematology, Volume 17, January-December 2026.
Background:Anti-thymocyte globulin (ATG) is used as prophylaxis for graft-versus-host disease (GvHD) and graft failure (GF) in allogeneic hematopoietic stem cell transplantation (allo-HSCT) for patients with transfusion-dependent thalassemia (TDT). ...